RESULTS Overall, the frequency of CAAs was 272/10,457 (2.60%), including 64 (0.62%) anomalous origin of coronary artery, 180 (1.72%) anomalies of intrinsic coronary arterial anatomy, 24 (0.23%) coronary artery fistula, and 4 (0.04%) number anomalies of coronary artery. Among anomalous origin of coronary artery, RCA originating from the left sinus of Valsalva (n¼27, 0.26%), high take-off of the RCA (n¼14, 0.13%) and LCX originating from the right sV (n¼12, 0.11%) were the top three types of anomalies. Among anomalies of intrinsic coronary arterial anatomy, the frequencies of hypoplasia is 1.24%, aneurysms 0.41%, and coronary atresia 0.01%. No gender differences were presented in the frequencies of most CAAs, except that LCX originating from the right sinus of Valsalva occurred more frequently in males than females (0.11% vs. 0.01%, p¼0.027). Furthermore, clinical relevance based classifications of CAAs were similar in the males and females.
METHODS Minipigs underwent a 90-minute balloon occlusion of the left anterior descending coronary artery followed by reperfusion. ILKengineered MSCs were intracoronary transplanted 7AE1 days after occlusion, as were vector-engineered MSCs and vehicle controls. Both cells were GFP-and iron-labeled before transplantation and were monitored in vivo by cardiac magnetic resonance imaging (CMR). CMR was also used to measure global and regional left ventricular (LV) function, scar size and perfusion.
RESULTS No impairment occurred in biological properties of MSCs following iron labeling at 50mg/ml. Significantly enhanced homing capacity of MSCs following ILK modification was revealed by MRI in vivo and confirmed by histological staining. Intracoronary transplantation of ILK-engineered MSCs improves global LVEF by 7.8% compared with baseline (P ¼ 0.03), and 11.7% when compared with vehicle (P ¼ 0.02) 15 days post-implantation. Regional LV contractile function was also recovered (P < 0.001), accompanied by substantially reduced scar size (P < 0.001), myocardial remodeling (P < 0.05), cell apoptosis (P < 0.001), and increased regional perfusion (P < 0.001) and cardiac cell proliferation (P < 0.001) in ILK-MSC treated minipigs versus vehicle controls. Vector-engineered MSC did not produce significant improvement in global LVEF or reduction in cardiac remodeling compared with baseline or vehicle controls, and generated less extent of all other favorable effects compared with ILK-modified MSCs.
CONCLUSIONS ILK-engineered allogeneic MSCs enhance regional and global LV function, reverse the remodeling process and restore regional perfusion with an improved homing capacity following intracoronary transplantation. Engineering MSCs with ILK has great potential implication for cell therapy in post-MI patients.
GW26-e1077
Impact of body mass index on mortality in patients with diabetes: Meta-analysis of 20 studies including 250,016 patients 2 ¼80.1%). Moreover, meta-regression analysis indicated that the beneficial prognostic impacts on overweight (Coefficient¼0.030; p¼0.041) and obesity (Coefficient ¼0.032; p¼0.010) were attenuated with clinical follow-up duration.
CONCLUSIONS Our meta-analysis indicated a significantly lower risk of mortality in overweight patients with diabetes compared to normal weight patients. However, the survival benefits of obesity were only observed among the elderly patients.
GW26-e2187
Association between Genetic Variation in NFKB1 and NFKBIA and Susceptibility to Coronary Artery Disease in a Chinese Han Population OBJECTIVES Coronary artery disease (CAD) is a chronic inflammatory disease involving the complex interplay between multiple genetic and environmental factors. As a central regulator of inflammation, NF-kB plays an important role in the development and progression of inflammatory diseases. The aim of this study was to investigate whether promoter polymorphisms in NFKB1 and NFKBIA gene contribute to CAD in a Chinese Han population.
METHODS This is a case-control study. NFKB1 promoter polymorphism (-94ins/del ATTG) and NFKBIA promoter polymorphisms (-881A/G, -826C/T, and -297C/T) were genotyped using TaqMan SNP genotyping assays in 1140 Han CAD cases and 1156 Han CAD-negative controls, and then NFKBIA haplotype blocks were reconstructed according to our genotyping data.
RESULTS No statistical significance was observed for the distribution frequency of the NFKBIA -881 A/G, -826 C/T, or -219 C/T allele, genotype and haplotype polymorphisms between CAD cases and controls. None of the studied NFKBIA SNPs were associated with CAD. There was significant difference in the distribution of the genotypes (P ¼ 0.001) and alleles (P¼0.001) of NFKB1-94ins/del polymorphism in CAD cases and controls. The homozygous variant genotype of NFKB1-94ins/del ATTG was consistently associated with increased risk of CAD among all participants after adjustment for covariates (OR¼1.505, 95% CI 1.190 to 1.903, P ¼ 0.001).
CONCLUSIONS In our study, we did not detect any relationship between NFKBIA promoter polymorphisms and CAD. However, the -94 ins/del polymorphism in NFKB1 promoter affects the susceptibility for CAD in Chinese Han population, providing a new insight into the genetic basis of CAD in Chinese Han population.
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Reduced T-cell thymic export reflected by sj-TREC in patients with coronary artery disease RESULTS Average copy numbers of sj-TREC per 10 6 T lymphocytes among patients with non-ST-elevation acute coronary syndrome (NSTACS), stable angina (SA) and controls were 877AE494, 1222AE539 and 1803AE 817, respectively (P<0.001). No significant difference of telomere length was found among three groups. NLR was significantly higher in NSTACS patients (3.9AE2.9) than SA patients (2.4AE1.1, P<0.01) and controls (2.1AE0.9, P<0.001). Negative correlation between sj-TREC and NLR was uncovered (R¼-0.3312, P<0.0001). Sj-TREC level between SA and NSTACS patients was significantly different in the 50-64 years cohort (P<0.001), but not in the 65-80 cohort. Sj-TREC level showed a negative correlation with age among healthy controls (R¼-0.5052, p¼0.0005) and SA patients (R¼-0.5158, p¼0.005), but not NSTACS patients (R¼-0.1415, P¼0.0991). Content of sj-TREC in high GS group (GS>41) was most significantly reduced than low GS group (GS <18) (P<0.001). Ordinal logistic regression analysis revealed that higher sj-TREC level was independently associated with absence of CAD (OR¼0.35, P<0.001) and low Gensini score (OR¼0.21, P<0.001).
CONCLUSIONS Significantly reduced sj-TREC level in SA and NSTACS patients mainly resulted from decreased thymic output rather than increased T cell proliferation. Patients with more sever inflammatory status had lower RTEs of T cells. Content of sj-TREC could be influenced both by age and CAD status. Sj-TREC level from elderly patients was too low to notice a significant difference between SA and NSTACS patients. Unlike the case with controls and SA patients, content of sj-TREC was so low in NSTACS patients that it appeared no longer significantly related to age among them. Patients with higher GS had more complicated plaques and might have poorer thymic function. Ordinal logistic regression analysis demonstrated that higher sj-TREC level was an independent protective factor to CAD status. In conclusion, accelerated thymic involution may be partly responsible for the development of CAD via the alteration of equilibrium of peripheral T cells compartments and interruption of maintained immune tolerance.
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Allocrytopine attenuates cardiac transmural dispersion of repolarization and protects ischemia reperfusion induced arrhythmias in rabbits Yicheng Fu, Ying Zhao, Yu Zhang, Zhongqi Cai, Qing Dan, Xi Chen, Tong Yin, Yang Li The Division of Cardiology, Chinese PLA General Hospital, Beijing, China OBJECTIVES Ischemia reperfusion injury is known to impaire cardiac function in ischemic heart diseases (IHD). Allocryptopine is a botanical alkaloid extracted from Corydalis decumbens (Thunb) Pers Papaveraceae. Lately great attention has been paid to its anti-arrhythmic effects. We hypothesized that allocryptopine can provide protection against ischemia reperfusion (I/R) injury though reducing transmural heterogeneity of repolarization in rabbit heart. METHODS The LADs ligation were conducted to block the blood flow and reperfuse the myocardium of 48 allocryptopine pretreatment rabbits. Body-surface electrocardiograms and monophasic action potential (MAP) were recorded before and after acute ischemia and reperfusion. Transmembrane action potential durations from epicardium, midcardium and endocardium were simultaneously recorded together with the occurrence of triggered activities and malignant ventricular arrhythmias.
RESULTS
The acute ischemia and subsequent reperfusion shortened the monophasic actin potential duration (MAPD) of epicardium, midcardium and endocardium and increased transmural dispersion of repolarization (TDR) in operation alone group. Treatment of allocryptopine preferentially prolonged the MAPD 50 and MAPD 90 of epicardium and endocardium rather than midcardium, thereby reduce the TDR of ischemia/reperfusion myocardium from 52.3AE8.7 ms/ 69.0AE8.0 ms to 30.5AE5.0 ms/ 33.0AE7.0 ms (P ¼0.002). Nine rabbits were observed early-afterdepolarizations (EADs) and thirteen rabbits were experienced frequent ventricular tachyarrhythmias during LADs ligation. Allocryptopine intervention successfully suppressed the I/Rinduced arrhythmias by 35.4% (P ¼0.018).
CONCLUSIONS Allocryptopine maintains the electrophysiological heterogeneity of repolarization among myocardial layers and effectively prevents I/R induced arrhythmias.
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Clinical effect of recombinant human brain natriuretic peptide combined with levosimendan on acute myocardial infarction complicated with heart failure Zhenda Zheng, Cailian Cheng, Dinghui Liu, Jianrui Zheng, Zhiming Song, Lin Chen, Xiaoxian Qian The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou 510630, China OBJECTIVES To observe the efficacy and safety of recombinant human brain natriuretic peptide (rh-BNP) combined with levosimendan in treating patients with acute myocardial infarction complicated with heart failure.
METHODS Hospitalized patients who suffered from anterior wall AMI with heart failure ( KillipIIwIII ) within 12 to 24 hours from the onset of chest pain were randomized into two groups (n¼30, respectively): control group (receiving dobutamine and/or cedilanid on the basis of essential therapy) and experimental group (receiving rh-BNP combined with levosimendan on the basis of essential therapy). The hemodynamics, clinical parameters of test and adverse events were observed before and after treatment.
RESULTS
In experimental group, compared with those before treatment, there were statistical differences in respiratory rate (RR), heart rate (HR), systolic blood pressure (SBP), arterial blood gas oxygen saturation (SaO2), cardiac index (CI), extravascular lung water index (EVLWI) at 2h and the following time points after treatment(all P <0.05). In control group, compared with those before treatment, there were statistical differences in RR, HR, SaO2, CI, EVLWI at 6h after treatment and in the next time points (all P <0.05). RR, HR, SBP, SaO2, CI, EVLWI at 2h and 6h after treatment had statistical differences between two groups, and the differences in RR, HR, CI, EVLWI persisted for 72 hours after medicine administration. There was a statistically significant difference between two groups in urine volume, plasma NT-proBNP concentration, left ventricular ejection fraction (LVEF) and length of stay in CCU (all P <0.05). For adverse events monitoring, there was no significant change between two groups in hepatic parameters, electrolyte level and coagulation function before and after treatment.
CONCLUSIONS rh-BNP combined with Levosimendon is superior to the conventional drugs in improving hemodynamics, increasing urine volume, decreasing the plasma NT-proBNP concentration, improving clinical symptoms, increasing LVEF, and reducing the length of stay in CCU in patients with acute myocardial infarction complicated with heart failure, which has better tolerance and safety.
GW26-e0268 Incidence and Predictors Of Prolonged Dual Antiplatelet Therapy Among Patients After Percutaneous Coronary Intervention
Bo Zheng, Jie Jiang, Yan Zhang, Ronghui Yu, Yong Huo, Tao Hong Peking University First Hospital OBJECTIVES The optimal duration of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) remains controversial. The present study sought to elucidate the frequency and predictors of DAPT beyond 12 months after stent deployment in Chinese population.
METHODS We examined the incidence of extended DAPT at 12 months follow-up among patients after successful PCI enrolled in a 28-site Chinese registry. Predictors of prolonged DAPT beyond 12 months were evaluated using multivariable cox proportional hazards model. RESULTS Among 2,130 patients, DAPT was continued in 46% (n¼983) beyond 12 months after stent implantation. There was a significant heterogeneity of DAPT duration among centers. Compared to those 
